{"id":"https://genegraph.clinicalgenome.org/r/e941ac1f-9d63-4eda-b233-810496d2693ev1.0","type":"EvidenceStrengthAssertion","dc:description":"Constitutional human pathogenic variants in the *POLD1* gene were first reported in association with autosomal dominant MDPL (Mandibular Hypoplasia, Deafness, Progeroid features, and Lipodystrophy) syndrome in 2013 (Weedon et al., 2013; PMID: 23770608). The syndrome had first been described in 2010 by Shastry et al, in seven unrelated patients diagnosed with an autosomal dominant segmental progeroid syndrome. These cases lacked the pathogenic variants in the known causal genes *LMNA* or *ZMPSTE24* (PMID:20631028). MDPL is characterized by distinctive facial features including dental overcrowding and mandibular hypoplasia, scleroderma-like skin tightening, telangiectasia, and ligament contractures as well as sensorineural hearing loss, subcutaneous fat loss and sequelae such as diabetes, loss of limb muscle mass, and male hypogonadism (PMID:23770608).  \nWe have curated the inheritance pattern for *POLD1* - related mandibular hypoplasia-deafness-progeroid syndrome as autosomal dominant, because a dominant mode of inheritance has consistently been reported (PMID: 23770608; Zuo et al., PMID: 36280868). Heterozygous variants, including an in-frame single amino acid deletion in the polymerase domain (c.1812_1814delCTC, p.Ser605del) that accounts for most cases, as well as several different missense variants, have been reported in individuals with MDPL syndrome. Missense variants associated with MDPL include p.Arg506Cys and a cluster of variants in the CysB domain of the protein. Phenotypic expression shows some variability (PMID: 31944473, 26172944). Unlike in MDPL, pathogenic variants in the exonuclease (proofreading) domain of *POLE* and *POLD1* are associated with colorectal and endometrial cancers (PMID: 23263490, 32792570). \nAt least 7 pathogenic variants (primarily de novo, including recurrent in-frame deletion or missense variants) in the *POLD1* gene have implicated in MDPL syndrome. These variants have been curated in at least 20 probands in 14 publications (PMIDs: 25131834, 38280868, 34517090, 35590056, 23770608, 29199204, 33369179, 28521875, 26350127, 28791128, 26172944, 33618333, 33863234, 28199729). More evidence is available to support the gene-disease association in the literature, but as the maximum score for genetic evidence (12 points) has been reached this has not been curated exhaustively. This gene-disease relationship is supported by loss of polymerase activity in vitro of DNA polymerase delta including *POLD1* with the in-frame deletion variant S605del (PMID: 23770608). Total points for the experimental evidence are 1. The total score for genetic and experimental evidence together are 13. \nPer criteria outlined by the ClinGen Lumping and Splitting Working Group, we found differences in inheritance pattern, mutational mechanism, and phenotype spectrum for variants causing MDPL syndrome vs. colorectal cancer and T-cell immunodeficiency. Therefore, we curated *POLD1* as a split curation for autosomal dominant mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome (OMIM: 615381). Autosomal dominant colorectal cancer susceptibility (OMIM: 612591) and autosomal recessive T- cell immunodeficiency (OMIM: 620836) will be curated separately in split curations.   \nIn summary, *POLD1* is definitively associated with autosomal dominant mandibular hypoplasia, deafness, progeroid features, and associated lipodystrophy. This has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time. Gene-Disease Validity Standard Operating Procedures (SOP) - SOP11. \n \n","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/e941ac1f-9d63-4eda-b233-810496d2693e","GCISnapshot":"https://genegraph.clinicalgenome.org/r/f040fe17-b319-4230-bb3f-8dde1ca5e6e1","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/f040fe17-b319-4230-bb3f-8dde1ca5e6e1_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10016","date":"2025-01-20T22:40:15.661Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/f040fe17-b319-4230-bb3f-8dde1ca5e6e1_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10016","date":"2025-01-20T17:00:00.000Z","role":"Approver"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f040fe17-b319-4230-bb3f-8dde1ca5e6e1_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f040fe17-b319-4230-bb3f-8dde1ca5e6e1_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/65dc21cf-e647-455c-9e50-1f0bbe775a23","type":"EvidenceLine","dc:description":"This recurring heterozygous single-codon deletion, S605del, in POLD1 within the polymerase active site results in a complete loss of polymerase activity.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/526402a0-b066-46d3-81fd-d7ac0a72d00c","type":"FunctionalAlteration","dc:description":"In vitro functional expression studies in E. coli revealed that the S605del mutant enzyme lost its DNA polymerase activity, while its exonuclease activity, though reduced compared to the wild type, remained present. The studies demonstrated a decoupling of the mutant enzymeâ€™s functions and suggested that the mutant protein could bind DNA but was unable to incorporate dNTPs. This inability to catalyze polymerization led to increased stalled replication forks, cellular senescence, and death. These findings implicate POLD1 in maintaining adipose tissue homeostasis.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23770608","rdfs:label":"In vitro polymerase and exonuclease assays "}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/f040fe17-b319-4230-bb3f-8dde1ca5e6e1_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6e8ab24a-5adb-4ddd-8ee6-eddc4c54a3b5","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6e8ab24a-5adb-4ddd-8ee6-eddc4c54a3b5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/36280868","allele":{"id":"https://genegraph.clinicalgenome.org/r/7d4647c2-3424-444c-9efa-bc744c9ba7b4","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002691.4(POLD1):c.3185A>G (p.Gln1062Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA406987461"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/78770115-149d-4db7-a6bf-1b487244389a","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/78770115-149d-4db7-a6bf-1b487244389a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35590056","allele":{"id":"https://genegraph.clinicalgenome.org/r/f9755fcf-9cd8-486f-93ca-eb4443a78389","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002691.4(POLD1):c.3219C>G (p.Ser1073Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA406987660"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/a75ff1f9-8fc9-401d-b888-31c58798b676","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a75ff1f9-8fc9-401d-b888-31c58798b676_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28521875","allele":{"id":"https://genegraph.clinicalgenome.org/r/ab762bb8-c953-4dea-8950-1f8dc3301f10","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002691.4(POLD1):c.3209T>A (p.Ile1070Asn)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA406987544"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/fbd01a95-035f-4753-9ea2-84bcf78a8d14","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fbd01a95-035f-4753-9ea2-84bcf78a8d14_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34517090","allele":{"id":"https://genegraph.clinicalgenome.org/r/26a0a3c9-36b6-4f65-abdd-7da46e158c64","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002691.4(POLD1):c.3214A>C (p.Thr1072Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA406987564"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/4be027f3-2f5e-46ce-9bd5-89390e5aacaa","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4be027f3-2f5e-46ce-9bd5-89390e5aacaa_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional studies by Weedon et al 2013 showed that a single amino acid deletion, Pol delta-S605del, in the polymerase active site of POLD1 can bind to DNA but does not promote polymerization and causes lipodystrophy due to complete loss of polymerase activity (PMID: 23770608).","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/4be027f3-2f5e-46ce-9bd5-89390e5aacaa_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33863234","allele":{"id":"https://genegraph.clinicalgenome.org/r/6a716aa8-d345-4866-a68d-8239afc3f18c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002691.4(POLD1):c.1812_1814del (p.Ser605del)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA144667"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/b5aadd2d-5454-45ee-b3f0-5b97856b8189","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b5aadd2d-5454-45ee-b3f0-5b97856b8189_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional studies by Weedon et al 2013 showed that a single amino acid deletion, Pol delta-S605del, in the polymerase active site of POLD1 can bind to DNA but does not promote polymerization and causes lipodystrophy due to complete loss of polymerase activity (PMID: 23770608).","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/b5aadd2d-5454-45ee-b3f0-5b97856b8189_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33369179","allele":{"id":"https://genegraph.clinicalgenome.org/r/6a716aa8-d345-4866-a68d-8239afc3f18c"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/60c03e02-7b9e-4014-b8e4-2626addef31b","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/60c03e02-7b9e-4014-b8e4-2626addef31b_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional studies by Weedon et al 2013 showed that a single amino acid deletion, Pol delta-S605del, in the polymerase active site of POLD1 can bind to DNA but does not promote polymerization and causes lipodystrophy due to complete loss of polymerase activity (PMID: 23770608).","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/60c03e02-7b9e-4014-b8e4-2626addef31b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26172944","allele":{"id":"https://genegraph.clinicalgenome.org/r/6a716aa8-d345-4866-a68d-8239afc3f18c"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/7c829921-cbf1-4492-ba91-c3bfd7fefb8e","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7c829921-cbf1-4492-ba91-c3bfd7fefb8e_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional studies by Weedon et al 2013 showed that a single amino acid deletion, Pol delta-S605del, in the polymerase active site of POLD1 can bind to DNA but does not promote polymerization and causes lipodystrophy due to complete loss of polymerase activity (PMID: 23770608).","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/7c829921-cbf1-4492-ba91-c3bfd7fefb8e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26350127","allele":{"id":"https://genegraph.clinicalgenome.org/r/6a716aa8-d345-4866-a68d-8239afc3f18c"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/e0316063-0b3d-49b7-ba2b-45d133226ad4","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e0316063-0b3d-49b7-ba2b-45d133226ad4_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional studies by Weedon et al 2013 showed that a single amino acid deletion, Pol delta-S605del, in the polymerase active site of POLD1 can bind to DNA but does not promote polymerization and causes lipodystrophy due to complete loss of polymerase activity (PMID: 23770608).","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/e0316063-0b3d-49b7-ba2b-45d133226ad4_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28791128","allele":{"id":"https://genegraph.clinicalgenome.org/r/6a716aa8-d345-4866-a68d-8239afc3f18c"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/ddc463c6-16fb-4aaa-96e1-8be1edc1cada","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ddc463c6-16fb-4aaa-96e1-8be1edc1cada_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Immunofluorescence staining of frozen liver sections from these patients showed abnormal nuclear morphology and lamin A/C distribution. Laboratory features include high testosterone levels and very low alkaline phosphatase levels associated with progeroid disorders with a pathogenic POLD1 - p.E1067K variant.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/ddc463c6-16fb-4aaa-96e1-8be1edc1cada_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28199729","allele":{"id":"https://genegraph.clinicalgenome.org/r/2de9c42a-096d-4923-ac80-2d33d4ea80d8","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002691.4(POLD1):c.3199G>A (p.Glu1067Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA406987511"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/f040fe17-b319-4230-bb3f-8dde1ca5e6e1_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a6190913-915a-410b-a50c-9005caee717e_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33863234","rdfs:label":"Zhou family","family":{"id":"https://genegraph.clinicalgenome.org/r/a6190913-915a-410b-a50c-9005caee717e","type":"Family","rdfs:label":"Zhou family","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/87dfe289-5640-4d99-b3f0-e179e6e05161","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33863234","rdfs:label":"Zhou proband","allele":{"id":"https://genegraph.clinicalgenome.org/r/6a716aa8-d345-4866-a68d-8239afc3f18c"},"detectionMethod":"A mutation in POLD1: c.1812_1814delCTC, (p.Ser605del)) was detected in the proband DNA based on whole exome sequencing, which was confirmed by Sanger sequencing.","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Exome sequencing","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/4be027f3-2f5e-46ce-9bd5-89390e5aacaa_variant_evidence_item"}}},"phenotypePositiveAllelePositive":1,"phenotypes":["obo:HP_0005328","obo:HP_0040270","obo:HP_0000855","obo:HP_0009125","obo:HP_0008619","obo:HP_0002155"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/87dfe289-5640-4d99-b3f0-e179e6e05161"}},{"id":"https://genegraph.clinicalgenome.org/r/82cf2a09-74d2-4cb9-aadf-62462d48faa3_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26172944","rdfs:label":"Lessel family BRA90250","estimatedLodScore":0.3,"family":{"id":"https://genegraph.clinicalgenome.org/r/82cf2a09-74d2-4cb9-aadf-62462d48faa3","type":"Family","rdfs:label":"Lessel family BRA90250","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/9b1cf12c-0a38-4a04-9239-ecb6675615d7","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26172944","rdfs:label":"Lessel proband BRA90250","ageType":"AgeAtReport","ageUnit":"Years","ageValue":38,"allele":{"id":"https://genegraph.clinicalgenome.org/r/6a716aa8-d345-4866-a68d-8239afc3f18c"},"detectionMethod":"PCR amplification of all coding exons and exon-intron boundaries of POLD1 using genomic DNA from affected individuals","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Sanger sequencing","secondTestingMethod":"PCR","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/d537171f-fd5a-417e-a993-88962e1b74ff_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26172944","allele":{"id":"https://genegraph.clinicalgenome.org/r/6a716aa8-d345-4866-a68d-8239afc3f18c"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}}},"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0009125","obo:HP_0005328","obo:HP_0000855","obo:HP_0040270","obo:HP_0008619","obo:HP_0002155"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/9b1cf12c-0a38-4a04-9239-ecb6675615d7"}},{"id":"https://genegraph.clinicalgenome.org/r/f62ec8ba-d8ad-4c4d-a4b3-bbe7d0e6ad08_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33618333","rdfs:label":"Murdocca family","estimatedLodScore":0.3,"family":{"id":"https://genegraph.clinicalgenome.org/r/f62ec8ba-d8ad-4c4d-a4b3-bbe7d0e6ad08","type":"Family","rdfs:label":"Murdocca family","member":{"id":"https://genegraph.clinicalgenome.org/r/b2736579-70d8-4b65-b330-fd34c510db56","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33618333","rdfs:label":"Murdocca proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":21,"allele":{"id":"https://genegraph.clinicalgenome.org/r/6a716aa8-d345-4866-a68d-8239afc3f18c"},"detectionMethod":"NGS was performed using a custom-built NGS panel that included some key genes related to progeroid syndromes ((LMNA, ZMPSTE24, WRN, POLD1, BANF1). \nSequence analysis was performed using the Ion S5 platform (Thermo Fisher Scientific). \nRun analysis was performed using the Integrated Genomics Viewer (IGV, Broad Institute).","firstTestingMethod":"Next generation sequencing panels","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/02c0d42f-8e95-45bc-ac5c-a83fd9d550d1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33618333","allele":{"id":"https://genegraph.clinicalgenome.org/r/6a716aa8-d345-4866-a68d-8239afc3f18c"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}}},"meetsInclusionCriteria":false,"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0008619","obo:HP_0000855","obo:HP_0001009","obo:HP_0009125","obo:HP_0040270","obo:HP_0002155","obo:HP_0005328"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/b2736579-70d8-4b65-b330-fd34c510db56"}},{"id":"https://genegraph.clinicalgenome.org/r/e7cecfe3-2a1c-4d99-87dc-6b1850251822_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26172944","rdfs:label":"Lessel family HD1010","family":{"id":"https://genegraph.clinicalgenome.org/r/e7cecfe3-2a1c-4d99-87dc-6b1850251822","type":"Family","rdfs:label":"Lessel family HD1010","member":{"id":"https://genegraph.clinicalgenome.org/r/eccedfde-ff6c-4e07-8b51-4b3371082e4e","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26172944","rdfs:label":"Lessel proband HD1010","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":6,"allele":{"id":"https://genegraph.clinicalgenome.org/r/6a716aa8-d345-4866-a68d-8239afc3f18c"},"detectionMethod":"PCR amplification of all coding exons and exon-intron boundaries of POLD1 using genomic DNA from affected individuals","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Sanger sequencing","secondTestingMethod":"PCR","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/cc75fa08-ea68-4c4d-b4dc-8a3a5dc169c4_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26172944","allele":{"id":"https://genegraph.clinicalgenome.org/r/6a716aa8-d345-4866-a68d-8239afc3f18c"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}}},"phenotypePositiveAllelePositive":1,"phenotypes":["obo:HP_0008619","obo:HP_0000855","obo:HP_0005328","obo:HP_0002155","obo:HP_0040270","obo:HP_0009125"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/eccedfde-ff6c-4e07-8b51-4b3371082e4e"}},{"id":"https://genegraph.clinicalgenome.org/r/1e549e5e-7a5d-4638-9b16-ad34d33f7644_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28199729","rdfs:label":"Ajluni family","estimatedLodScore":0.3,"family":{"id":"https://genegraph.clinicalgenome.org/r/1e549e5e-7a5d-4638-9b16-ad34d33f7644","type":"Family","rdfs:label":"Ajluni family","ethnicity":{"id":"cg:HispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/ff2f217b-6379-4dd7-a2e1-db1531c06291","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28199729","rdfs:label":"Ajluni proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":14,"allele":{"id":"https://genegraph.clinicalgenome.org/r/2de9c42a-096d-4923-ac80-2d33d4ea80d8"},"ethnicity":{"id":"cg:HispanicOrLatino"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0002155","obo:HP_0000855","obo:HP_0005328","obo:HP_0040270","obo:HP_0009125","obo:HP_0008619"],"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/ddc463c6-16fb-4aaa-96e1-8be1edc1cada_variant_evidence_item"}}},"meetsInclusionCriteria":false,"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0002155","obo:HP_0009125","obo:HP_0000855","obo:HP_0040270","obo:HP_0005328","obo:HP_0008619"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/ff2f217b-6379-4dd7-a2e1-db1531c06291"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/cc75fa08-ea68-4c4d-b4dc-8a3a5dc169c4","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cc75fa08-ea68-4c4d-b4dc-8a3a5dc169c4_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional studies by Weedon et al 2013 showed that a single amino acid deletion, Pol delta-S605del, in the polymerase active site of POLD1 can bind to DNA but does not promote polymerization and causes lipodystrophy due to complete loss of polymerase activity (PMID: 23770608).","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/cc75fa08-ea68-4c4d-b4dc-8a3a5dc169c4_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/ec89e3d8-874a-4c4d-8865-11b6c1068001","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ec89e3d8-874a-4c4d-8865-11b6c1068001_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional studies by Weedon et al 2013 showed that a single amino acid deletion, Pol delta-S605del, in the polymerase active site of POLD1 can bind to DNA but does not promote polymerization and causes lipodystrophy due to complete loss of polymerase activity (PMID: 23770608).","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/ec89e3d8-874a-4c4d-8865-11b6c1068001_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29199204","allele":{"id":"https://genegraph.clinicalgenome.org/r/6a716aa8-d345-4866-a68d-8239afc3f18c"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/53adc2dc-fce5-4d7c-b537-146a23f5dc5c","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/53adc2dc-fce5-4d7c-b537-146a23f5dc5c_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional studies by Weedon et al 2013 showed that a single amino acid deletion, Pol delta-S605del, in the polymerase active site of POLD1 can bind to DNA but does not promote polymerization and causes lipodystrophy due to complete loss of polymerase activity (PMID: 23770608).","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/53adc2dc-fce5-4d7c-b537-146a23f5dc5c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28521875","allele":{"id":"https://genegraph.clinicalgenome.org/r/6a716aa8-d345-4866-a68d-8239afc3f18c"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/02c0d42f-8e95-45bc-ac5c-a83fd9d550d1","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/02c0d42f-8e95-45bc-ac5c-a83fd9d550d1_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"In vitro characterization study for the recurrent inframe del variant p.(Ser805del) using patient-derived dermal fibroblasts showed severe nuclear envelope abnormalities, presence of micronuclei, accumulation of prelamin A, altered cell growth, cellular senescence, and delayed DNA damage response.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/02c0d42f-8e95-45bc-ac5c-a83fd9d550d1_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/58bc03ae-14eb-4c50-9cfc-fb4fb0b0e649","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/58bc03ae-14eb-4c50-9cfc-fb4fb0b0e649_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"In silico protein modeling, the S605 deletion profoundly affects the structure of the polymerase active site, specifically by disrupting the hydrogen bond between the substrate trinucleotide and the catalytic aspartate residue. Similarly, functional results indicate that a single amino acid deletion, Pol delta-S605del, in the polymerase active site of POLD1 can bind to DNA but does not catalyze polymerization and causes lipodystrophy due to complete loss of polymerase activity.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/58bc03ae-14eb-4c50-9cfc-fb4fb0b0e649_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23770608","allele":{"id":"https://genegraph.clinicalgenome.org/r/6a716aa8-d345-4866-a68d-8239afc3f18c"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/c099f175-e71b-4a8c-a29f-de19e267c370","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c099f175-e71b-4a8c-a29f-de19e267c370_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26172944","allele":{"id":"https://genegraph.clinicalgenome.org/r/4746069d-f666-42db-9f4a-0c98553defae","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002691.4(POLD1):c.1519C>T (p.Arg507Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10583829"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/9dbb50f2-9104-4d8d-9600-7b9825f1bdd8","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9dbb50f2-9104-4d8d-9600-7b9825f1bdd8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25131834","allele":{"id":"https://genegraph.clinicalgenome.org/r/4746069d-f666-42db-9f4a-0c98553defae"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/fce02b45-103f-4cf3-84c5-8069e1f47313","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fce02b45-103f-4cf3-84c5-8069e1f47313_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional studies by Weedon et al 2013 showed that a single amino acid deletion, Pol delta-S605del, in the polymerase active site of POLD1 can bind to DNA but does not promote polymerization and causes lipodystrophy due to complete loss of polymerase activity (PMID: 23770608).","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/fce02b45-103f-4cf3-84c5-8069e1f47313_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26172944","allele":{"id":"https://genegraph.clinicalgenome.org/r/6a716aa8-d345-4866-a68d-8239afc3f18c"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/d642ed24-829d-41d7-b1eb-391f0a2097d6","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d642ed24-829d-41d7-b1eb-391f0a2097d6_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"In silico protein modeling, the S605 deletion profoundly affects the structure of the polymerase active site, specifically by disrupting the hydrogen bond between the substrate trinucleotide and the catalytic aspartate residue. Similarly, functional results indicate that a single amino acid deletion, Pol delta-S605del, in the polymerase active site of POLD1 can bind to DNA but does not catalyze polymerization and causes lipodystrophy due to complete loss of polymerase activity.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/d642ed24-829d-41d7-b1eb-391f0a2097d6_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23770608","allele":{"id":"https://genegraph.clinicalgenome.org/r/6a716aa8-d345-4866-a68d-8239afc3f18c"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/d537171f-fd5a-417e-a993-88962e1b74ff","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d537171f-fd5a-417e-a993-88962e1b74ff_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional studies by Weedon et al 2013 showed that a single amino acid deletion, Pol delta-S605del, in the polymerase active site of POLD1 can bind to DNA but does not promote polymerization and causes lipodystrophy due to complete loss of polymerase activity (PMID: 23770608).","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/d537171f-fd5a-417e-a993-88962e1b74ff_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":9845,"specifiedBy":"GeneValidityCriteria11","strengthScore":13,"subject":{"id":"https://genegraph.clinicalgenome.org/r/2P3RmLZWuK4","type":"GeneValidityProposition","disease":"obo:MONDO_0014157","gene":"hgnc:9175","modeOfInheritance":"obo:HP_0000006"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_f040fe17-b319-4230-bb3f-8dde1ca5e6e1-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}